← SynDRA
KO-143
SynDRA canonical compound SYN0087448 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ABCG2 |
|---|
| Mechanism of action | Breast cancer resistance protein inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Breast cancer resistance protein inhibitor
Cross-references
Synonyms
- Ko 143
- Ko143
- Ko143 cpd
- RefChem:151339
- DTXCID50388901
- Ko143 hydrate
- C26H35N3O5
- MFCD11042273
- orb1296146
- SCHEMBL16645259
- SCHEMBL30395014
- CHEBI:95026
- GTPL10007
- EX-A745
- GLXC-07396
- Ko 143?
- LSM-6260
- LTA05493
- BDBM50305083
- MFCD19053160
- s7043
- AKOS016005202
- CS-0298
- NCGC00378799-07
- AS-77372
- HY-10010
- BRD-K64642496-001-01-6
- BRD-K64642496-001-03-2
- I3O
- (3S,6S,12aS)-1,2,3,4,6,7,12,12a-Octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester
Look up KO-143 in the interactive SynDRA portal →